Healthcare provider profile · identity verified

Kevin E Mckeighen, DO

Family Practice · ENUMCLAW, WA · NPI 1841205283

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	627	182
Lisinopril	Lisinopril	412	114
Omeprazole	Omeprazole	401	136
Levothyroxine Sodium	Levothyroxine Sodium	389	100
Amlodipine Besylate	Amlodipine Besylate	276	85
Losartan Potassium	Losartan Potassium	202	63
Metoprolol Succinate	Metoprolol Succinate	186	53
Gabapentin	Gabapentin	183	54
Alendronate Sodium	Alendronate Sodium	172	50
Metformin Hcl	Metformin Hcl	159	43
Tamsulosin Hcl	Tamsulosin Hcl	153	49
Pantoprazole Sodium	Pantoprazole Sodium	145	41
Rosuvastatin Calcium	Rosuvastatin Calcium	144	44
Albuterol Sulfate Hfa	Albuterol Sulfate	134	56
Metformin Hcl Er	Metformin Hcl	129	42
Trazodone Hcl	Trazodone Hcl	124	48
Famotidine	Famotidine	121	44
Escitalopram Oxalate	Escitalopram Oxalate	117	38
Sertraline Hcl	Sertraline Hcl	111	33
Montelukast Sodium	Montelukast Sodium	101	26
Hydrochlorothiazide	Hydrochlorothiazide	100	31
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	100	22
Fluticasone Propionate	Fluticasone Propionate	88	39
Meloxicam	Meloxicam	87	39
Jardiance	Empagliflozin	77	19
Bupropion Xl	Bupropion Hcl	75	24
Duloxetine Hcl	Duloxetine Hcl	74	23
Glipizide	Glipizide	71	24
Ezetimibe	Ezetimibe	70	27
Ozempic	Semaglutide	68	15
Fluoxetine Hcl	Fluoxetine Hcl	64	18
Quetiapine Fumarate	Quetiapine Fumarate	60	12
Ipratropium Bromide	Ipratropium Bromide	57	16
Pravastatin Sodium	Pravastatin Sodium	57	18
Ketoconazole	Ketoconazole	55	34
Baclofen	Baclofen	53	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	53	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	53	14
Donepezil Hcl	Donepezil Hcl	52	suppressed
Spironolactone	Spironolactone	52	14
Methylprednisolone	Methylprednisolone	50	48
Carvedilol	Carvedilol	48	14
Eliquis	Apixaban	48	19
Memantine Hcl	Memantine Hcl	48	11
Trulicity	Dulaglutide	48	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	47	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	47	suppressed
Allopurinol	Allopurinol	46	15
Tramadol Hcl	Tramadol Hcl	43	suppressed
Amoxicillin	Amoxicillin	42	32
Chlorthalidone	Chlorthalidone	41	16
Doxycycline Hyclate	Doxycycline Hyclate	41	38
Esomeprazole Magnesium	Esomeprazole Magnesium	41	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	41	suppressed
Methocarbamol	Methocarbamol	40	16
Oxycodone Hcl	Oxycodone Hcl	40	suppressed
Synthroid	Levothyroxine Sodium	40	suppressed
Paroxetine Hcl	Paroxetine Hcl	39	11
Finasteride	Finasteride	38	12
Galantamine Hbr	Galantamine Hbr	38	suppressed
Mupirocin	Mupirocin	37	18
Spiriva Respimat	Tiotropium Bromide	35	suppressed
Diclofenac Sodium	Diclofenac Sodium	34	16
Nitroglycerin	Nitroglycerin	34	22
Potassium Chloride	Potassium Chloride	34	18
Symbicort	Budesonide/Formoterol Fumarate	34	suppressed
Xarelto	Rivaroxaban	32	11
Buspirone Hcl	Buspirone Hcl	31	suppressed
Clopidogrel	Clopidogrel Bisulfate	31	16
Alprazolam	Alprazolam	30	14
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	30	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	30	suppressed
Topiramate	Topiramate	30	13
Acyclovir	Acyclovir	29	12
Bisoprolol Fumarate	Bisoprolol Fumarate	29	suppressed
Bupropion Hcl Sr	Bupropion Hcl	29	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	29	20
Pregabalin	Pregabalin	29	suppressed
Propranolol Hcl	Propranolol Hcl	29	suppressed
Warfarin Sodium	Warfarin Sodium	29	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	28	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	26	suppressed
Furosemide	Furosemide	24	12
Metoprolol Tartrate	Metoprolol Tartrate	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	19
Benazepril Hcl	Benazepril Hcl	23	suppressed
Dutasteride	Dutasteride	23	suppressed
Naproxen	Naproxen	23	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Lamotrigine	Lamotrigine	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	suppressed
Sucralfate	Sucralfate	22	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	13
Lovastatin	Lovastatin	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	suppressed
Solifenacin Succinate	Solifenacin Succinate	20	suppressed
Lisdexamfetamine Dimesylate	Lisdexamfetamine Dimesylate	19	suppressed
Estradiol	Estradiol	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	16	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Azithromycin	Azithromycin	14	12
Nifedipine Er	Nifedipine	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Valacyclovir	Valacyclovir Hcl	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Diazepam	Diazepam	13	suppressed
Fluconazole	Fluconazole	13	12
Latanoprost	Latanoprost	13	suppressed
Nystatin	Nystatin	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Galantamine Er	Galantamine Hbr	12	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Prednisone	Prednisone	12	11
Rybelsus	Semaglutide	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Celecoxib	Celecoxib	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error